Autoantibodies, Anti-Soluble Liver Antigen (Sla), Autoimmune Hepatitis
NIY is the FDA product code for Autoantibodies, Anti-Soluble Liver Antigen (Sla), Autoimmune Hepatitis, a class II device type, regulated under 21 CFR 866.5660. FDA's definition for this code reads: "ELISA for the detection of anti-SLA (soluble liver antigen) antibody of the IgG class. Intended to aid in the diagnosis of conditions with elevated levels of anti-SLA antibody including autoimmune hepatitis". As of , FDA records hold 3 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- NIY
- Device name
- Autoantibodies, Anti-Soluble Liver Antigen (Sla), Autoimmune Hepatitis
- FDA definition
- ELISA for the detection of anti-SLA (soluble liver antigen) antibody of the IgG class. Intended to aid in the diagnosis of conditions with elevated levels of anti-SLA antibody including autoimmune hepatitis
- Regulation
- 21 CFR 866.5660
- Device class
- Class II
- Review panel
- Immunology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 3
- Ingested recalls
- 0
Clearances, product code NIY
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2002 | 1 |
| 2012 | 1 |
| 2013 | 1 |
Applicants with the most clearances
Product code NIY| Applicant | Clearances |
|---|---|
| Euroimmun US Inc. | 2 |
| Inova Diagnostics, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
